Pipeline » Product Pipeline
| Drug | Stage of Development | |||||
Research |
Preclinical |
Phase I |
Phase II |
Phase III |
Approval |
|
| MTR107 | Intradialytic Hypotension | |||||
| MTR106 | Migraine | |||||
| MTR1051 | Cardiac Surgery-Related Hypotension | |||||
1 MTR-105 has been a registered and approved drug in Eastern Europe since 1997, where a large amount of data has been gathered from clinical use mainly for the specific indications of epidural and hypotension associated with Cardiac surgery.
In 2003, the FDA granted Meditor IND (Investigational New Drug) number 66,505 authorizing the beginning of two separate Phase II clinical trials : MTR107 for the treatment of Intradialytic hypotension and MTR105 for the treatment of hypotension associated with Cardiac surgery.
